Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- USD | -.--% | +1,06% | +2,41% |
2020 | Transcript : Correvio Pharma Corp. - Shareholder/Analyst Call | |
2019 | Transcript : Correvio Pharma Corp., Q3 2019 Earnings Call, Nov 14, 2019 |
CA 2018 | 28,67 M 25,93 M | CA 2019 | 32,63 M 29,51 M | Capitalisation | 27,28 M 24,67 M |
---|---|---|---|---|---|
Résultat net 2018 | -16 M -14,47 M | Résultat net 2019 | -35 M -31,65 M | VE / CA 2018 | 5,13 x |
Dette nette 2018 | 25,92 M 23,44 M | Dette nette 2019 | 33,9 M 30,66 M | VE / CA 2019 | 1,87 x |
PER 2018 |
-7,1
x | PER 2019 |
-0,68
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 86,23% |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+15,09% | 74,45 Md | |
+11,35% | 9,18 Md | |
+54,35% | 5,03 Md | |
-12,85% | 5,02 Md | |
+1,60% | 3,82 Md | |
-20,85% | 2,41 Md | |
+16,88% | 2,39 Md | |
-29,25% | 2,27 Md | |
+24,62% | 2,26 Md |
- Bourse
- Actions
- Action CORV
- Action CORV